[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 17, Issue 1 (6-2019) ::
3 2019, 17(1): 1-10 Back to browse issues page
Biomarker efficacy in multiple sclerosis diagnosis and treatment
MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (2264 Views)
The goal in studies concerning biomarkers in autoimmune diseases is finding a marker which fluctuates in correlation with the disease’s severity and settles within normal borders after effective treatment. This marker would later be used as an efficient tool in diagnosis and analysis of medicine clout. It seems the most cogent biomarkers are those measurable in serum or plasma. MS is a neurological disease common within the young adult population with a predictable course, often leading to life-immersing disability. The prognosis, however difficult and limited, is currently possible via diagnostic tests (brain MRI) or clinical information (severity and degrees of disability).  Many studies have been conducted in an effort to detect an adequate biomarker. It is still often overlooked that a reliable biomarker should both be clinically applicable and functional is prognosis; as this is what could lead to timely treatment.
Keywords: MS biomarkers, Autoimmune disease, Demyelination, MicroRNAs
Full-Text [PDF 342 kb]   (566 Downloads)    
Article Type: Review Article | Subject: Neuropharmacology
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

GHASEMI SAKHA F, MOAZZENI S M, ETESAM F, AZIMI SAEEN A, VAEZI G. Biomarker efficacy in multiple sclerosis diagnosis and treatment. 3 2019; 17 (1) :1-10
URL: http://ijpt.iums.ac.ir/article-1-387-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 17, Issue 1 (6-2019) Back to browse issues page
مجله داروشناسی و درمان شناسی ایران Iranian Journal of Pharmacology and Therapeutics
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4657